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ABSTRACT 
 
 Histatin 5 is a potent antifungal peptide endogenously produced by the parotid, 
sublingual and submandibular glands in humans.  The potent antifungal properties 
afforded provide histatin 5 as an enticing biological therapeutic in treating oral 
candidiasis as well as other opportunistic yeast infections in immunocompromised 
individuals.  As Candida albicans gains resistance to the current pharmacotherapies, it is 
pertinent to elucidate novel approaches in treating this pathogen.  While a plethora of 
research has been performed studying histatin 5, its mechanism of action within C. 
albicans and other yeast species remains unresolved.  Herein, we report on histatin 5 and 
suggest a mechanism of killing within a Saccharomyces cerevisiae model.   
 Using haploid genetic knockouts, several genes of interested were tested in viable 
culture at the 50% lethal dose of histatin 5.  Cells were further analyzed as being resistant 
or hypersensitive to histatin 5.  Genes of interest and protein gene products were 
categorized in six distinct categories including cell surface transport, ion channels and 
 v 
osmoregulation, ionic/osmotic stress response, calcineurin regulation, oxidative stress 
response and finally cell wall and plasma membrane integrity. 
 Histatin 5 internalizes via interactions with Ssa1, an Hsp70 family member, via 
initial binding then subsequent transfer to polyamine transporters Dur3 and Ptk2.  Once 
inside the cell, histatin 5 operates through at least two pathways. Histatin 5 causes a 
deregulation of ionic gradients and membrane potential through cell surface ion channels 
Pma1 and Trk1.  Initial osmotic stress activates regulatory pathways including high 
osmolarity glycerol (Hog1) pathways as well as the calcium dependent phosphatase 
calcineurin.  While the osmotic stress is the immediate response to histatin 5 
internalization, it is believed that histatin 5 also travels to the actively respiring 
mitochondria via interactions with cytosolic Ssa1.  Histatin 5 enters the mitochondria and 
disrupts the electron transport chain ultimately producing highly reactive free radicals 
and reactive oxygen species.  These species consequently damage DNA, lipids and 
proteins and are the main factors involved cell death. 
 While further research is necessary, the establishment of necessary gene products 
for histatin 5 induced killing in S. cerevisiae grants mechanistic clarity, hopefully 
allowing for the development and advancement of histatin 5 mediated therapies in the 
future.  
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I. INTRODUCTION 
 
  Histatins comprise a family of small, cationic peptides ranging in molecular size 
from 3.0 to 4.9 kDa.  These relatively small peptides, rich in histidine, were first 
discovered in human salivary secretions from the three major salivary glands; the parotid, 
submandibular and sublingual glands, by Bonilla and colleagues in the 1960s(1),(2).  
Histatins within whole saliva exhibit both antibacterial and antifungal properties 
demonstrating their relative importance within the innate, non-immune host defense 
system(3),(4).  Of the major family members, Histatin 5 is the smallest (24 amino acid) yet 
most potent antifungal peptide(5).  
 Candida albicans is one of the many yeast species regulated by the antifungal 
properties of histatin.  Deregulation of C. albicans can cause oral candidiasis (thrush) in 
immuno-compromised patients such as those undergoing chemotherapy or organ 
transplantations as well as those suffering from HIV infection(6).  Clinically relevant is 
the ability of this yeast species as well as others to develop resistance to the common 
pharmaceutical azole or amphotericin treatments.  As such, the potency of this peptide as 
well as its mechanism of action is of great interest to further elucidate the potential of the 
small peptide as a future therapy. 
 Herein, histatin 5 and its potential mechanism of action within a Saccharomyces 
cerevisaie model will be described as well as additional relevant hypotheses applicable to 
the antifungal properties of the peptide. 
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I.a. Histatins  
 Salivary histatins are produced and secreted by the parotid, submandibular and 
sublingual major salivary glands, as well as some minor salivary glands including the 
deep posterior lingual von Ebner’s gland(2).  As demonstrated by Hand and colleagues, 
histatins are found immunocytochemically located in granules within serous acinar cells 
of the parotid and submandibular glands, the serous demilune cells within the 
submandibular and sublingual glands, and the serous tubular alveolar secretory units of 
the von Ebner’s glands(7).  Histatin production, however, is limited to the serous 
components of the glandular parenchyma and is not associated with mucus production by 
the sublingual and submandibular glands.  To date, histatins have only been found in the 
salivary secretions of humans and Old World monkeys, such as Macaca fascicularis; and 
are not detectable in tear fluid, sweat, nasal, bronchial, or cervical mucus, seminal fluid, 
or blood plasma of these species(7). 
 On a subcellular level, histatins predominate within the secretory granules at the 
apical surface of the serous exocrine cell.  The small peptides are also found distributed 
in the rough endoplasmic reticulum (rER) and golgi apparatus of serous acinar cells, 
suggesting the packaging pathway necessary for granular, merocrine secretion.  Within 
the granules themselves, histatin is packaged with other secretory proteins such as 
lysozyme, lactoferin, amylase, agglutinin and cAMP receptor proteins. In the parotid and 
von Ebner’s glands, the distribution of histatin within the granule is quite uniform, with 
no apparent sub-localization.  However, in the submandibular and sublingual glands, 
histatin is distributed randomly throughout the secretory granules and vary from 
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localizing to the dense core, in association with the amylases and other proteins, to the 
lighter periphery, associated with the higher molecular weight agglutinins, as 
demonstrated by electron microscopy(8).  These differences could be attributed to 
variability in the storage, packaging, and secretion rates of the three major salivary 
glands. 
 The parotid gland produces the highest concentration of histatin of the major 
salivary glands.  Such a phenomenon is unsurprising, as the parotid gland is purely serous 
in secretion with the serous acinar cells comprising the majority of parenchyma.  
However, even though the parotid gland has the highest density of serous acinar cells, the 
salivary flow rate is far less than that of the submandibular and sublingual glands.  As 
such, measurable salivary histatin over time is greatest from the submandibular and 
sublingual glands. The parotid produces on average 53.3 µg/mL of histatin with a flow 
rate of 0.04 mL/min per each of the paired glands.  The submandibular and sublingual 
glands produce an average of 13.2 µg/mL of histatin with an average flow rate of 0.14 
mL/min per individual gland(9) (Table 1).  Along with these data, Johnson and colleagues 
also demonstrated that age, gender and various mechanical and physiological stimuli 
could alter production and secretion of histatin(9). 
 The flow rates for parotid, submandibular and sublingual saliva all demonstrated a 
4-fold increase or greater upon gustatory stimulation with 0.1M citric acid as compared to 
baseline.  The parotid gland secreted the highest amount of histatin upon gustatory 
stimulation, as seen by a 26-fold increase in peptide concentration.  In the submandibular 
and sublingual glands, both secretion rates as well as concentration of histatin within the 
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gland increased.  Mechanical stimulation of each gland produced insignificant changes in 
salivary flow rate and histatin production as compared to controls(9). 
Table 1:  Histatin concentration in parotid and submandibular/sublingual secretions.  
Parotid Saliva  
Flow rate (mL/min per gland) 0.04 ± 0.02 
Protein (mg/mL) 6.67 ± 1.93 
Histatin (µg/mL) 53.3 ± 15.5 
Histatin (µg/min) 0.74 ± 0.18 
µg Histatin/mg protein 8.47 ± 2.31 
Submandibular/Sublingual Saliva  
Flow rate (mL/min per gland) 0.14 ± 0.04 
Protein (mg/mL) 1.43 ± 0.17 
Histatin (µg/mL) 13.2 ± 2.90 
Histatin (µg/min) 1.47 ± 0.51 
µg Histatin/mg protein 10.13 ± 3.20 
Adapted from Johnson et al., 2000 
 Gender and ethnicity did not significantly alter any variable in the production and 
secretion of histatin.  Age however, played a significant role as demonstrated by a 
decrease in flow rate from stimulated submandibular/sublingual glands with increasing 
age.  The highest decrease in flow rate was demonstrated in the cohorts encompassing 
45-64 years of age.  Johnson and colleagues concluded that susceptibility of oral Candida 
infections increases with elderly age groups as a direct result of decreased histatin 
production and secretion(9). 
 All members of the histatin family are derived from precursor family members 
histatin 1 and histatin 3; peptides encoded on chromosome 4q13 by genes HTN1 (HIS1) 
and HTN2 (HIS2) respectively(10).  Histatin 1 is the largest peptide of the salivary 
histatins at 38 amino acids and undergoes modification via phosphorylation at serine-2.  
Histatin 3 lacks any modification and is 32 amino acids long(11).  Histatins 1 and 3 
 5 
demonstrate 89% overall sequence homology and 95% exon sequence homology 
suggesting their relatively similar protein structures and functions(10).  As stated earlier, 
all members of the histatin family ultimately derive from proteolytic cleavage of either 
histatin 1 or 3 gene products.  Proteolysis occurs at two different levels: immediately 
after processing the peptide within the gland, then by the oral environment which can be 
triggered by bacterial and host-derived enzymes(3).  Histatin 2 is a fragment of histatin 1 
corresponding to the carboxy-terminal residues 1-26(5).  Histatins 2 and 4 are not found in 
fresh parotid saliva and are suggested to be the autoproteolytic degradation of peptides 
histatin 1 and histatin 3 after several hours.  Histatins 5-12 on the other hand are found in 
fresh saliva and are due to trypsin and chymotrypsin-like cleavages of the parent histatin 
3 peptide, post processing in the parotid, submandibular and sublingual glands.  Most 
notable of the group is Histatin 5, the 24 N-terminal amino acids of Histatin 3 processed 
within the acinar cell prior to secretion (Figure 1).   
Figure 1:  The amino acid sequences of histatins 1 and 3 and cleavage products histatins 2 and 5. 
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 Out of all the histatin members, Histatins 1, 3 and 5 represent the majority of the 
histatin peptides present in human saliva and all demonstrate anti-candidal activity(5),(12).  
Histatin 5, is the smallest histatin family member, yet is the most potent in antifungal 
activity, while histatin 1 is the largest and has the least killing activity(5),(13).  Histatin 1 
and 3 demonstrate efficacy at either log-phase growth or stationary phase respectively.  
Specifically, histatin 3 inhibits germination of certain yeast species preventing 
exponential growth.  Histatin 5, however, seems to be effective during both log-phases 
and stationary phases of C. albicans life cycle, and is resilient to drastic changes in pH 
within a range of 4 to 8(13).  Thus, histatin 5, through its potency and resilience to 
environmental conditions demonstrates the highest potential for clinical efficacy and 
therapeutic modulation against oral fungal infections.  
 
I.b. The Biological Properties of Histatins 
 The biological activities of histatins occur upon secretion into the oral cavity and 
encompass a wide variety of functional purposes.  As stated prior, the three major 
histatins (1, 3, 5) all display antimicrobial and antifungal properties.  Histatin 1, unlike 
histatins 3 and 5, also functions to restore and protect the integrity of tooth enamel.  
Studies have shown that histatins along with other acidic proline-rich proteins and 
slatherin form heterotypic complexes that bind preferentially to hydroxyapatite, the most 
abundant macromolecule within the enamel pellicle, in turn regulating remineralization 
of teeth and decreasing the formation of dental caries; a complex disease characterized by 
the demineralization of tooth structure(14).  Histatin 1 inhibits the formation of 
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hydroxylapatite crystals and stabilizes other mineral-solute interactions in the oral fluid 
thus regulating the homeostatic balance necessary for healthy enamel surfaces(5).  
 Recently, histatin 1 along with histatin 2 and 3 have been found to play an 
important role in the stimulation of wound closure and healing within the oral cavity, as 
seen through epithelial cell migration(15),(16).  In rodent saliva the main contributing factor 
to wound recovery was thought to be epidermal growth factor (EGF) and nerve growth 
factor (NGF).  Oudhoff and colleagues have suggested that in human saliva, EGF does 
not play as quintessential a role as the salivary histatins 1, 2 and 3.  The study published 
in 2008 demonstrated that histatin 1, L-histatin-2 and histatin 3 accelerated wound closure 
in the physiologically relevant concentration range 5-100 µg/mL, without causing cell 
death.  Histatin 5 however, demonstrated negligible enhancement of wound recovery 
suggesting the C-terminus (last 8 amino acids) of the parent peptide (histatin 3) as the 
important binding domain for activation of oral epithelial cells.   
 A stereospecific interaction also was important, as the D-enantiomer of histatin 2 
had reduced ability to enhance wound closure and no ability to enhance cell migration.   
D-histatin-2 demonstrated poor wound healing properties due to inadequate binding and 
activation of oral epithelial cells, however it did demonstrate histatin-mediated killing of 
C. albicans, suggesting that the receptor-mediated interactions involved in wound repair 
may be chiral in nature, while the antifungal properties and surface receptor binding to C. 
albicans may be achiral (Table 2)(15). 
 Histatins 1, 2 and 3 are internalized into oral epithelial cells via an active energy-
dependent mechanism.  To clarify this process, histatin peptides were added to 
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supernatant surrounding TRK146 oral epithelial cells for 20 hours at 37°C, and uptake 
was measured by decreased concentrations in the supernatant.  Histatins 1, L-histatin-2 
and 3 were transcytosed into the cells by active uptake mechanisms but D-histatin-2 was 
not, again affirming the chiral selectivity of surface epithelial receptors(15).    
 The extracellular signal-related kinase (ERK1/2) signal-transduction pathway and 
not the EGF-induced mitogen-activated protein kinase (p38MAPK) pathway is believed 
to be the key route through which histatin-mediated wound closure operates.  Oudhoff 
and colleagues demonstrated that histatin-induced wound closure could be abolished 
through treatment of epithelial cells with U0126, a competitive inhibitor of ERK1/2 but 
not with SB203580 and AG1478, small molecule inhibitors of p38MAPK and epidermal 
growth factor receptor (EGFR) respectively(15).  
Table 2: Relative wound closure properties and candidacidal activity of histatins.  
Peptide Wound closure* Candidacidal activity (LC50)** 
Histatin 1 1.22 ± 0.12 6.0 ± 0.3 
Histatin 2 1.36 ± 0.13 13.8 ± 1.9 
D-Histatin 2 0.99 ± 0.14 10.7 ± 1.2 
Histatin 3 1.21 ± 0.12 1.1 ± 0.1 
Histatin 5 1.01 ± 0.11 2.3 ± 0.1 
Adapted from Oudhoff et al., 2008 
*Value = mean ± standard deviation, n = 4; calculated as (X0-X16h)/(C0-C16h), where X0 = width of 
scratch made in a well of confleuent TR146 cells at time 0h, X16h = width of scratch after 16h 
exposure to experimental condtion, C0 = width of scratch at time 0h, C16h = width of scratch after 
16h exposure to control condition(15).  
 
**Value = Measured fluorescence of propridium iodide binding to DNA in midlog phase 
Candida albicans cells treated with various histatins at LC50(15). 
 
 In addition to regulating tooth mineralization, wound closure and possessing anti-
candidal properties, the histatin family has been implemented in a multitude of various 
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actions.  Histatins enhance glycolytic activity of the salivary micro-organism(17); 
demonstrate bactericidal activity against Streptococcus mutans, Actinomyces viscosus, A. 
naeslundii, A. odontolyticus and Porphyromonas gingivalis(18); induce histamine release 
from rat-isolated mast cells(19); inhibit hemagglutinating activity, trypsin-like proteinase, 
clostripain and collagenase activity of P. gingivalis(20),(21),(22); inhibit lipopolysaccharide-
mediated activities(23); exhibit tannin-binding activity(24); and demonstrate fungicidal 
activity against Candida albicans, C. stellatoidea, C. tropicalis, C. glabrada, C. 
parapsilosis, C. guillermondii, C. lambica, C. pseudotropicalis, C. krusei, Trichosporon 
pullulans, Saccharomyces cerevisiae and Cryptococcus neoformans(1),(25),(26),(27).  
 Even with multi-functional properties, histatins have relatively short half-lives 
within the lumen of the oral-esophageal canal, but seem to retain antifungal activity over 
the course of degradation, suggesting a minimal amino acid sequence necessary for 
killing efficacy.  Histatins, upon secretion, are rapidly degraded by salivary proteases and 
bacterial enzymes within the oral cavity.  To test fungicidal activity post degradation, 
Helmerhorst and colleagues incubated histatin 5 with C. albicans and measured 
respective growth over 72h.  A 50% decrease in peptide activity was noted at the 24h 
endpoint where whole histatin 5 peptide was present at a negligible level (Table 3).  
However, at the final time-point taken (72h), the histatin fragments left still demonstrated 
up to 20% antifungal activity(3).  While proteolysis is quite rapid in the oral cavity, 
histatins are being constantly replenished through the production of saliva from the major 
salivary glands, attenuating the long lasting antifungal properties even post degradation. 
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Table 3:  Histatin 5 levels over 72h along with % antifungal activity against C. albicans. 
Incubation time (h) Histatin 5 levels (%) Antifungal activity (%) 
0 95.6 ± 2.4 100 ± 0 
4 68.0 ± 3.0 95.6 ± 4.3 
8 48.0 ± 1.2 100 ± 0 
12 27.1 ± 1.6 100 ± 0 
24 0 ± 0 48.6 ± 0.8 
48 0 ± 0 23.6 ± 0.3 
72 0 ± 0 19.9 ± 1.6 
Adapted from Helmerhorst et al., 2006 
  
I.c. Candida albicans 
 As aforementioned, while histatins demonstrate a plethora of biological 
properties, the majority of research done on the peptide family is in regards to their potent 
fungicidal activity, because of the potential for therapeutic modulation.  Oral candidiasis 
is an increasing concern among individuals who experience reduced salivary flow 
(xerostomia) due to immunosuppression linked HIV infection, organ transplantation or 
chemotherapy, and is a criterion for the staging and progression of AIDS(28),(29),(30).  With 
reduced salivary flow comes a reduction in the amount and secretion rate of non-immune 
defense system macromolecules such as histatin.  As such, C. albicans, an opportunistic 
pathogen, thrives in the mucosal membranes of patients who are immunosuppressed and 
tends to colonize the entire oral cavity, nasal cavity, and upper esophageal cavity leading 
to oropharyngeal and esophageal candidiasis. 
 Candida albicans is a normal human commensal that is delivered at birth and 
colonizes the gastrointestinal tract in healthy individuals.  C. albicans, a diploid, 
eukaryotic fungi, encompasses a rather complex life cycle including a sexual mating 
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phase as well as growth phases from unicellular yeast to multicellular hyphae in vivo.   
Within mucosal infections, hyphal Candida predominates and arises from dimorphic 
transition of resident unicellular yeast.  Dimorphic transition consists of the formation of 
short germ tubes, which upon further branching and elongation produce the adult 
mycelium.  The main inducer of the hyphal dimorphic transition is N-Acetyl-D-
glucosamine, a signaling molecule involved in quorum sensing: the cell-to-cell signaling 
necessary for biofilm production.  Nets of intertwining and overlapping mycelia form the 
pathogenic and hard to treat biofilm on the oral epithelia.  To be specific, drug-
recalcitrant biofilm encompasses the mycelia net along with entrapped neutrophils, 
macrophages, tissue matrix and cellular debris.  Once biofilms are present phenotypically 
in patients, the clinical term “thrush” is used to describe the inflammation(30). 
 During the sexual lifecycle of C. albicans the white-opaque transition occurs, a 
phenomenon in which pathogenicity is assumed to intensify through increased adherence 
and biofilm formation within the oral mucosa. Colonies transition from a white to 
yellow/opaque phenotype via activation through N-Acetyl-D-glucosamine. 
 These virulent hyphal Candida cells resist phagocytosis and invade the epithelial 
tissue through endocytosis or active penetration via the secretion of aspartyl proteinase 
(Sap) protein.  Saps degrade a variety of host proteins such as keratin, fibronectin and E-
cadherin, the proteinaceous make up of cell-to-cell junctions.  Not only do Saps aid in the 
migration into epithelial surfaces, they also posses the ability to hydrolyze antibodies as 
well as complement of the humoral immune system(30).  Because of the evasion 
mechanisms and increased virulence of pathogenic Candida, especially in 
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immunosuppressed patients, it is necessary to evaluate current and future therapeutic 
models for the advancement of treatment of oral candidiasis. 
 
I.d. Treatment for oral candidiasis and clinical implications 
 The current treatment for oral candidiasis today includes 5-fluoro-cytosine (5-FC) 
(a pyrimidine analogue) and drugs within the polyene, azole and the echinocandin 
classes(31).  While the mechanistic action of these drugs differ in C. albicans, an 
increasing concern of drug tolerance and resistance has become the driving force for the 
discovery of new non-toxic and efficacious biological therapies.   
 The fluorinated pyrimidine analogue 5-FC interferes with DNA replication and 
causes aberrant RNA synthesis once incorporated into the replicating cell.  The polyenes 
such as amphotericin B, candicidin, nystatin and rimocidin, among others, form pores in 
lipid bilayers through their actions as heterocyclic amphipathic molecules, which bind to 
and aggregate sterols in the plasma membrane.  Once pores are formed, an efflux of 
cations such as K+ occurs which leads to cell death through a loss of membrane potential 
and osmotic stress(31).   
 The azole antifungals include triazoles such as fluconazole and ravuconazole; 
imidazoles such as ketoconazole and clomitrazole; and thiazoles such as abafungin. 
These compounds interfere with sterol biosynthesis, specifically, the azoles inhibit 
cytochrome P450 14α-lanosterol demethylase, an enzyme involved in the ergosterol 
biosynthetic pathway.  A disruption at this level not only depletes the ergosterol content 
of membranes but also causes an accumulation of toxic sterol intermediates (14-α-
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methylated precursors) affecting the fluidity of the membrane, deregulating chitin 
synthases and ultimately halting growth(31),(32). 
 The final class of drugs, the echinocandins and cyclic lipopeptides were 
discovered in the soil fungus Papularia sphaerosperma in 1974(33).  Since the class 
discovery synthetic pharmaceutical mimics have been produced and include caspofungin, 
micafungin and anidulafungin.  These drugs interfere with cell wall biosynthesis through 
the non-competitive inhibition of (1,3)-D-β-glucan synthase, an enzyme involved in 
glycosylation of surface proteins on the cell wall, ultimately leading to organizational 
disruption and cell wall malfunction.  The current antifungal treatments against C. 
albicans infections and other opportunistic fungi thusly operate primarily through 
disruption at the cell wall and cell membrane leading to downstream activation of stress 
response pathways such as osmotic and oxidative stress (Figure 2)(31). 
Figure 2: Targets of current antifungal drugs in C. albicans.  Adapted from Cannon et al., 2007.  
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 Even with a variety of pharmaceutical therapies, C. albicans rapidly develops 
resistance through mutations as well as up-regulation of membrane drug-pumps leading 
to advanced aggressive biofilm formation, especially in immuno-compromised patients.  
Resistance to the pyrimidine analogues stems from mutations in uracil 
phosphoribosyltransferase (Fur1p), which does not allow for the conversion of 5-
fluorouracil to 5-fluorouridine monophosphate.  Mutations in ERG3 decrease the amount 
of ergosterol produced by the cell, limiting the effectiveness of the polyenes.  Point 
mutations at Erg11p, cause an overexpression of the protein and confer resistance to 
fluconazole binding, along with the overexpression of the major superfamily drug efflux 
pump Mdr1p and the ATP-binding cassette (ABC) pumps Cdr1p/2p respectively.  
Finally, while overexpression of the efflux pumps seem to have little effect on the 
transport of echinocandins, point mutations in the (1,3)-β-glucan synthase subunit Gsc1p 
confer resistance to these drugs in C. albicans(31).  
 Along with resistance, high doses of polyenes and azoles can have toxic side 
effects including drug-induced hepatitis and nephro/adrenotoxicity due to inhibition of 
the synthesis of testosterone and cortisol, as well as cross-inhibition of mammalian P450-
dependent enzymes. Not only do these drugs pose harmful side effects, they also 
demonstrate cross reactivity with vincristine, cyclosporine A and ritanovir, drugs given to 
patients receiving chemotherapy, transplants and undergoing HAART therapy for AIDS 
respectively(32). With the increase in azole-resistant Candida strains and toxic side 
effects, it is pertinent to readdress current pharmacotherapies and to elucidate the use of 
small peptides and other biologics in their potential role as future anti-fungal therapies.   
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Histatin 5 not only demonstrates potent anti-fungal properties, but also provides no 
adverse side effects to mammalian cells, and affords a model in which to develop new 
clinical therapies without increasing the population of resistant C. albicans strains.  
  
I.d. Current hypotheses of histatin 5-induced cell death in C. albicans 
 The mechanism of histatin 5-induced cell death in Candida and other yeast 
species is an actively pursued topic by many research institutions. The most significant 
publications have been on two main mechanisms argued by Edgerton and Oppenheim 
and will be described herein.   
 Early studies of histatin 5 suggested its mechanism of action in C. albicans 
involved inserting into the cell membrane (and vacuoles) producing a membrane-
spanning pore, ultimately leading to ion efflux, increased cell permeability and eventually 
death through loss of intracellular components.  This hypothesis was anchored upon the 
fact that histatin 5 is an amphipathic molecule that changes structure based on its 
environment.  In aqueous environments, histatin 5 forms random coils, but in non-
aqueous environments i.e. in close proximity to cellular membranes, the peptide is 
believed to adopt an alpha-helical secondary structure, allowing for its spontaneous 
insertion into membranes(34).   
 However, more recent data has suggested this hypothesis unlikely. Situ and 
colleagues argue through two-dimensional NMR that histatin 5 has weak amphipathicity 
and is too small of a peptide at 36Å to form a true alpha helix that can anchor and span 
large plasma membranes including C. albicans at 70Å(35).  Situ and colleagues further 
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demonstrated that if histatin 5 needs to form an alpha helix for antifungal activity, then a 
proline-rich variant of histatin 5 should demonstrate little to no activity.  However, the 
peptide with no helical content demonstrated similar fungicidal activity to wild-type 
histatin 5, again suggesting a limited basis for alpha-helical membrane pore formation(36).  
C. albicans also possesses a cell wall highly decorated in mannans and glucans that could 
form electrostatic interactions with histatin 5, limiting its ability to have access to the 
plasma membrane(6). 
 One possible mechanism of action that has been proposed by Edgerton and 
colleagues is the ability of histatin 5 to bind to the cell envelope through interactions at 
the Ssa1/2p (stress seventy a subfamily) receptor, internalize through a different 
transporter and deregulate cationic gradients within the cell, leading to an efflux of K+, 
Mg2+ and ATP, and ultimately cell death through loss of cytocellular fluid 
noncytolytically(37).   
 The Ssa 1 and Ssa 2 proteins are members of the heat shock protein 70 (Hsp70) 
family that are constitutively expressed in both C. albicans and S. cerevisiae.  Within C. 
albicans there are only two members of the Ssa family: Ssa 1 and Ssa 2, which are 
primarily located in the cytosol.  These proteins, within the cytosol, function as 
chaperones that translocate normal as well as mis-folded proteins across membranes to 
vacuoles and the proteasome for degradation.  They are also found along the cell surface 
both at the membrane and cell wall even though they lack an N-terminal secretion signal.  
As such, they must be directed to the surface via a non-conventional secretion pathway.  
Like all other Hsp70 proteins, the Ssa proteins contain an ATPase domain and a peptide-
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binding domain.  The ATPase domain cleaves ATP to allow for the binding and release 
of substrate at the peptide-binding domain(38),(39),(40).  While the exact mechanism of 
histatin5 binding to Ssa1/2p is not fully understood, it is believed that this event does not 
in itself allow for the translocation to the cytosol, rather a secondary transporter is 
necessary.  It is also hypothesized that once in the cell, histatin activates cellular necrosis 
through multiple effectors, the binding event itself is not the killing event.  
 Kumar and colleagues have suggested that the Ssa1/2p moieties pass along the 
bound histatin 5 to polyamine transport proteins Dur3 and Dur31 in C. albicans(41).  
These active transporters move polyamines including putrescine, spermidine, spermine, 
urea, S-adenosylmethionine, glutamic acid and lysine as well as other polycationic 
molecules.  It is proposed that histatin 5, because of its multiple lysine and histidine 
residues, demonstrates competitive binding with spermidine, a cell-signaling molecule 
similar in amino acid composure, as demonstrated by reduced intracellular histatin 5 in C. 
albicans grown in media-enriched with spermidine(41).   
 Once internalized histatin 5 regulates the loss of ATP and K+ through Trk1p, the 
principal K+ transporter in C. albicans.  Trk1p operates as a proton-coupled system that 
mediates both K+ and Cl- currents at the cell membrane(42).  ATP is not a homeostatic 
substrate for Trk1p.  Rather, Baev and colleagues suggest that Cl- movement via Trk1p is 
altered upon histatin 5 binding which then allows for the efflux of larger anions such as 
ATP.  Interestingly, histatin-induced killing can be halted through the administration of 
4,4'-Diisothiocyano-2,2'-stilbenedisulfonic acid (DIDS) a classic anion channel 
inhibitor(42).  Once ATP is released, an autocrine signaling system is activated where 
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effluxed ATP binds to the cytotoxic P2X7-like receptor on the cell surface, inducing cell 
death(43).  Like the mammalian P2X7 receptor, the P2X7-like receptor found on C. 
albicans surface mediates ATP-induced cell death as it recruits pannexins (ATP-gated 
pores in the membrane)(43).  Once this non-lytic event occurs, the osmotic stress response 
pathway is activated through the Hog1 MAPK system, which mediates a transcriptional 
response that leads to an excess loss of water from the cytosol and an increase in 
osmolytes such as glycerol(44).  Interestingly, this proposed mechanism through Hog1 
demonstrates some overlap with the other significant theory of histatin 5 induced killing 
in C. albicans proposed by Oppenheim and colleagues.  
 The other theory states cellular necrosis via histatin 5 is due to the formation of 
reactive oxygen species (ROS), such as peroxides formed during the inhibition of 
respiration at the NADH:ubiquinone reductase level (complex I) and the 
ubiquinol:cytochrome c reductase level (complex III) along the respiratory chain in C. 
albicans(45).  It has been shown through the use of a non-specific ROS probe (2’,7’-
dichlorodihydrofluorescein diacetate) that histatin 5 increases ROS by more than 3-fold 
in C. albicans(46).  The direct route of translocation is still unknown, however, 
microscopy studies using fluorescein isothiocyanate (FITC)-labeled histatin 5 
demonstrated localization to the mitochondria along with a concomitant dissipation of 
mitochondrial membrane potential(47),(48).  Of note was the fact that histatin 5 only kills 
yeast that are actively respiring, and cells undergoing anaerobic respiration show 
increased resistance to the peptide(45).  Histatin 5 does not induce programmed cell death 
within C. albicans through mitochondrial disruption as there have been no measureable 
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levels of cytochrome c upon treatment(49).  As such, the ROS generated must cause 
irreversible damage at both the protein and DNA level within the cell. 
 Histatin 5 also displays the ability to bind to metal ions, a chelating property that 
can contribute to the production of ROS in vitro(50),(51).  Studies by Houghton and 
colleagues have suggested that production of ROS, in particular hydrogen peroxide, 
superoxide and the hydroxyl radical, can be due to metal ions complexed with histatin 5 
in the presence of reductants such as molecular oxygen and NADH at the mitochondrial 
level, as demonstrated through a spin trapping CYPMPO model.  These ions include 
highly reactive Cu(I,II) and Fe(II,III) as well as Ni(II) and Zn(II)(50).  Not only can these 
metal complexes form destructive free radicals within the cell, it has also been shown that 
the Zn-histatin complex allows for increased mobility of the peptide through fusion of 
unilamellar vesicles to the membrane(51). 
 To test these two hypotheses and to clarify the mechanism of action of histatin 5, 
a double allele knockout library of roughly 4800 genes were examined in a similar yeast 
species Saccharomyces cerevisiae. 
  
I.e. Saccharomyces cerevisiae 
 Saccharomyces cerevisiae is a non-pathogenic yeast that is used in preparation of 
many baked goods and alcoholic products.  Like C. albicans, S. cerevisiae is a eukaryotic 
organism, however, genetically S. cerevisiae is haploid, and as such allows for ease of 
genetic manipulation through the production of true allelic knockouts.  Haploid S. 
cerevisiae has 16 chromosomes encoding approximately 5800 open reading frames for 
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proteins of both known and unknown functions(52).  What makes S. cerevisiae a model 
organism for biological application is its ease of preparation and genetic modification.  
The yeast is incredibly proliferative when grown at optimal temperature (30°C) with 
generation times between 2 and 4 hours.  The species can also be stored at -70°C with no 
harmful freeze to thaw effects(52). 
 S. cerevisiae can grow aerobically when seeded in glucose or maltose rich 
mediums.  Active respiration occurs to allow for the production of ATP from these 
simple sugars.  Even in situations of limited nutrient availability, S. cerevisiae can exit 
the life cycle and enter a state of dormancy.  Within the life cycle, budding is the main 
form of division, however, in haploid state, S. cerevisiae can present two mating types: a 
and α, where upon mating, a resultant diploid cell can further enter meiosis and sporulate 
back to the haploid form(52). 
 Due to the high pathogenicity of C. albicans, S. cerevisiae has been used as a 
model organism to analyze associated genes and proteins across species(53),(54).  The great 
degree of haploid manipulation as well as the complete sequenced genome thus affords S. 
cerevisiae as the appropriate tool to elucidate the mechanistic pathway for histatin 5 
induced killing. 
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II. AIMS AND OBJECTIVES 
 The research presented herein will provide a more detailed understanding of the 
action of histatin 5 within Saccharomyces cerevisiae, as a comparative tool to parallel 
histatin 5’s action in Candida albicans.  Through the use of growth inhibition assays at 
the LD50 of histatin 5 several open reading frames (ORF), which confer resistance to 
histatin 5, have been identified and will be described elucidating a potential killing 
pathway. 
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III.  MATERIALS AND METHODS 
 
III.a.  Yeast deletion library 
 A deletion library of S. cerevisiae Mat α strains BY4742 and BY4739 was 
obtained from Invitrogen (Carlsbad, CA).  4828 individual gene mutants were arrayed 
into 96 well plates and reseeded into plates containing yeast peptone dextrose media 
(YPD) at pH 6.8 containing 100 µg/mL geneticin (G418).  To prepare the library, a gene 
disruption deletion cassette was constructed via two-step PCR.  First, two 74 bp primers 
(UPTAG and DNTAG) were used to amplify the KanMX gene from the pFA6-kanMX4 
DNA.  These primers have 18 bp of homology upstream and downstream of the ORF 
undergoing manipulation.  With integration of the KanMX gene to the S. cerevisiae 
mutants, Geneticin (G418) resistance was established.  In the second PCR step, 45 bp 
primers specific to the flanking sequence of each ORF were used to extend the 18 bp 
homologies to 45 bp.  With an increase of specificity and length of primer sequences, the 
probability of successful deletion increased during mitotic recombination (Figure 3). 
 Once the gene cassettes were created, a standard lithium-acetate transformation 
took place in order to introduce the DNA into diploid S. cerevisiae.  Cells were then 
selected with G418.  After sporulation, haploids MATa and MATα were isolated to 
confirm the gene deletion.  Two independent haploids of each strain were mated and 
resulted in a homozygous diploid that contained the specific gene knockout.  Several 
initial sporulations resulted in non-viable haploids.  As such, the respective gene deleted 
resulting in non-viable cells was deemed “essential.”  Two attempts were made to create 
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mutants with specific ORF deletions.  After two attempts, new primers with a flanker 
sequence of 90 bp were used in the initial PCR.  
Figure 3: Yeast deletion library construction via chromosomal integration by homologous 
recombination. Adapted from Saccharomyces Genome Deletion Project. 
 
III.b.  Lethal dose 50% (LD50) determination  
 Parent wild-type strains BY4742 and BY4739 were obtained from the American 
Type Culture Collection (Rockville, MD).  5 µL of each parent strain were grown 
overnight in 5 mL of yeast peptone dextrose media (YPD) pH 6.8 in a shaking incubator 
at 200 rpm and 30°C.  The optical density (O.D.) of each yeast culture was measured at 
405 nm in a standard spectrophotometer.  Cultures exceeding an O.D. of 0.8 were diluted 
to a value below 0.8 and remeasured.  Growth cultures were further diluted in YPD to a 
volume of parent culture equivalent to 10 O.D. units/µL culture (2 x 104 – 2 x 105 colony 
forming units/mL). 
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 To set up the assay to determine the LD50 of histatin 5 in Saccharomyces 
cerevisiae, Costar clear flat-bottom 96 well plates were seeded with a concentration curve 
of histatin 5 in YPD pH 6.8 along with wild-type yeast.  Initially, 100 µL of YPD pH 6.8 
was added to rows A and H.  50 µL of YPD pH 6.8 was added to the subsequent rows (B-
G).  2.5 µL of YPD was removed from row H and replaced with 2.5 µL histatin 5 in 
dH2O (aliquoted at 9 µg/µL) resulting in a final concentration of 750 nM.  The peptide 
was then serially-diluted through the transfer of 50 µL fluid from row H continually to 
row C creating a concentration curve ranging from 225 ng/µL to 7.03 ng/µL (750 nM – 
23.4 nM).  Overnight cultures were diluted to 10 O.D./µL, and 50 µL of diluted culture 
was added to each row except row A, diluting every well by half (Figure 4).  Finally 
plates were sealed with film to prevent evaporation and incubated for 48h at 30°C.  Row 
A served as a negative broth-sterility control while row B served as a positive no-histatin 
5 growth control.  Each plate was read 48h post-incubation at 405 nm endpoints.  The 
resultant LD50 was determined at the concentration where growth of S. cerevisiae was at 
50% that of the positive control. 
Figure 4: Serial dilution of histatin 5 to find LD50 in wild type S. cerevisiae. 
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III.c.  Turbidity assay with the gene knockout library 
 Specific genes of interest were selected from the deletion library as determined by 
research and the biochemical pathway(s) involved.  A similar assay was prepared to that 
of the assay to determine the LD50 of histatin 5.  A concentration curve of histatin 
encompassing the respective LD50 and two standard deviations above and below was 
plated on four separate plates.  12 separate mutants of interest and 4 mutant controls were 
grown overnight at 0.5 µL culture in 5 mL YPD + G418 (100 µg/mL) pH 6.8.  Samples 
were run in triplicate with each well containing a final volume of 50 µL culture, YPD, 
and histatin as described previously.  Rows A and B were free of either yeast or histatin 
and were deemed broth sterility control and positive no-histatin control respectively.  
Plates were sealed with film to prevent evaporation and were grown in a 30°C incubator 
for 48h.  Plates were read at 405nm endpoints and data was collected and analyzed as 
percent-growth above the controls.  Any mutant that demonstrated ≥ 15% growth above 
the control was labeled as resistant to histatin at LD50.  Data were plotted in excel and 
analyzed statistically using Graph Pad Prism software (San Diego, CA).  Mutants 
demonstrating resistance were ranked based on growth percent above control at LD50 and 
were retested. 
 
III.d.  Database search 
 Yeastgenome.org was utilized to gain additional insight into mutants with 
deletions in ORFs that conferred resistance to histatin 5.  To assess function of the 
deleted gene and gene product, close attention was made to what the protein was, where 
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it was located in the cell, what other proteins it may interact with and what biochemical 
pathway it plays a role in.  String-db.org was also utilized to identify other proteins that 
interact with the ORF gene product, as it is an algorithm that searches for interactions 
based on referenced literature and ranks the strength of interaction from protein to 
protein. 
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IV.  RESULTS 
 
 After significant literature research, 44 genes were chosen and tested in our 
growth assay to demonstrate relative resistance to histatin 5 in order to elucidate the 
mechanism of action of the peptide in S. cerevisiae.  Gene products were grouped in six 
distinct categories including cell surface transporters and their regulators, ion channels 
and their regulators, osmotic/ionic stress response proteins, FK506 and calcineurin 
associated genes, reactive oxygen species regulating proteins, and cell wall integrity 
genes.  Each of these genes and gene products will be discussed along with several other 
interesting ORFs in order to propose a hypothesis of histatin 5 induced killing in S. 
cerevisiae.  All data are represented as average percent growth over control ± standard 
error of the mean (SEM) with significance based on two-tailed t tests. 
 
IV.a. Genes associated with cell surface transporters 
 Several genes with surface transporters as gene products were tested to determine 
if their loss affects histatin 5 uptake in S. cerevisiae. These genes included Ptk2, Dur3, 
Gap1, Agp2, Sam3, Tpo4, Tat1 and Ssa1.  All these genes function as transporters or 
receptors at the cell surface and can shuttle macromolecules including amino acids, 
spermine, spermidine and other polyamines into the cytoplasm.  It is theorized that 
histatin 5 in fact enters the cell as a means of killing, and as such, these transporters were 
tested to elucidate the mechanism of entrance.   
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 Ptk2 (93.83 ± 1.45% growth, p < 0.0001) is a high affinity, spermidine transport, 
serine/threonine protein kinase associated with the cell membrane that regulates a variety 
of pathways including but not limited to ion transport.  Ptk2 primarily transports small 
charged molecules called polyamines, which are essential for cellular functions but are 
closely regulated due to their toxicity at high cellular concentrations(55).  The three main 
naturally occurring polyamines include putrescine, spermidine, and spermine; highly 
charged species that affect cell growth and survival via interactions with nucleic acids, 
proteins and membranes(55).   While Ptk2 is the main polyamine transporter in S. 
cerevisiae, Dur3 (100.70 ± 2.33%, p <0.0005) another spermidine permease has been 
proposed by Kumar and colleagues as a polyamine transporter through which histatin 5 
may be internalized in C. albicans(41).  Gap1 (91.00 ± 6.35%, p < 0.0048), Agp2 (100.00 
± 1.53%, p < 0.0002), Sam3 (86.67 ± 0.88%, p < 0.0001) and Tpo4 (62.00 ± 5.57%, p < 
0.008), are all additional spermidine transporters that also demonstrated significant 
resistance to histatin 5 treatment upon knockout.   Finally the tat1Δ encoding Tat1, a 
valine, tyrosine and tryptophan amino-acid permease, which also transports L-cysteine, 
demonstrated 69.50 ± 10.97% growth over control when treated with histatin 5 at 28 
ng/µL (p < 0.024).  With these data, the initial entrance of histatin 5 into S. cerevisiae 
may be regulated through non-specific polyamine transport, as demonstrated by high 
resistance to the peptide upon knockout of these genes (Figure 5). 
 Previous research has suggested that initial binding of histatin 5 to C. albicans 
prior to internalization occurs at the cell surface localized Ssa1 receptor, a co-chaperone 
and member of the heat shock protein family Hsp70(38),39,(40).  The Ssa1 mutant (ssa1Δ) 
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was tested and demonstrated significant resistance to histatin 5-mediated cell death with 
55.67 ± 4.10% growth over control (p < 0.0054).  While binding to Ssa1 is a possibility, 
it is hypothesized that in C. albicans the initial binding event itself does not allow for the 
highly charged protein to cross, rather a binding event to Ssa1 allows for the transfer of 
histatin 5 to Dur3 or any of the other polyamine transporters(41). 
 
 
 
 
 
 
 
 
 
Figure 5:  Normalized percent growth of S. cerevisiae cell surface transporter gene knockouts at 
LD50 of histatin 5. 
 
 Wild type genes ptk2, dur3, gap1, agp2, sam3 and tpo4 encode a spermidine/polyamine 
transporter.  Tat1 encodes a histidine/other amino acid transporter.  Ssa1 encodes a 
member of the heat shock protein 70 family.  All these gene products can be found at the 
cell surface with the exception of Ssa1, which can be found both at the cell surface and in 
the cytosol.  Δ signifies a haploid knockout. p < 0.05 (*), p < 0.005 (**), p < 0.001 (***). 
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IV.b. Genes associated with ion channels and their regulation 
 An activated Ptk2 transporter is required for the subsequent phosphorylation of 
Ser899 on the H+/ATPase Pma1, which in turn activates the channel(56),(57).  Pma1 is in the 
family of P-type cation pumps, and through the generation of a proton gradient, drives the 
active transport of nutrients and other small molecules across the plasma membrane via 
H+-symport.  Under non-homeostatic conditions, this vastly important ATPase, through 
efflux of H+, can drive movement of K+ ions leading to depolarization and loss of 
membrane potential, concurrently with an osmotic shift, leading to loss of cytosolic fluid.  
Unfortunately, a pma1Δ mutant was not available to test in our assay, however, a family 
member pma2Δ mutant was tested and demonstrated significant change in percent growth 
as compared to the control when treated with histatin 5 (69.33 ± 4.91%, p < 0.005).  A 
knockout of the regulatory subunit for the plasma membrane H+/ATPase Pma1 (pmp1Δ) 
was tested in addition and demonstrated significant resistance to histatin 5-induced 
killing with 63.50 ± 3.50% growth over control (p < 0.0351).  These results suggest that 
post internalization through Ptk2, histatin 5 deregulates the major H+/ATPase Pma1 
which causes initial hyperosmolar sensitivity. 
 Sky1 is a constitutively active serine/threonine protein kinase whose primary 
function is the processing and nuclear export of mRNAs through sequential 
phosphorylation of serine/arginine (SR)-type mRNA binding proteins at their dipeptide 
repeats(58).  Forment and colleagues have suggested that Sky1p plays a role in salt 
tolerance as well, specifically through its interaction with both the Ptk2 kinase and the 
Trk1 potassium transporter(59). When tested in our assay, the sky1Δ mutant demonstrated 
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high resistance to histatin 5-mediated degradation (95.67 ± 2.33%, p < 0.0006).  Sky1 
protein may act as a negative modulator of the Trk system, whereby disruption of its gene 
cassette leads to an increase in Trk1-mediated K+ uptake, followed by a decrease in 
membrane potential and a concomitant decrease in the uptake of toxic cations 
(tetramethylammonium, excess Na+, Li+, spermine, hygromycin B and Mn2+)(59). 
 Trk1 is the principal potassium transporter in C. albicans.  Initially Baev and 
colleagues believed Tok1, another potassium transporter, was the primary effector site of 
diffusion for voltage stabilization, however, when mutants were tested with histatin 5, 
only a slight increase in viability was observed(60).   A rapid ATP efflux in C. albicans 
post histatin 5 treatment was also noted by Edgerton and colleagues when testing Trk1 
mutants(42).  This phenomenon could only be explained through increased anion 
permeability or plasma membrane degradation.  It is argued that Trk1 mediates Cl- along 
with ATP conductance through the exchange of K+.  When treated with anion-channel 
blocker 4, 4'-diisothiocyanatostilbene-2, 2'-disulfonic acid (DIDS), C. albicans net ATP 
loss was decreased as well as histatin 5 induced cell death(42).  It would be necessary then 
to modulate Trk1p at an effector level as well, not only through gene knockouts, to 
understand its relevance in histatin 5-mediated degradation.  In our assay the trk1Δ 
mutant demonstrated the highest resistance to histatin 5-mediated killing at LD50 (129.70 
± 6.77%, p < 0.0027).    
 Several other ion channels including cytosolic and vacuolar Ca2+/ATPases were 
tested.  Trk1 and Pma1 are the principal voltage gated plasma membrane channels, and 
upon their deregulation, the subsequent ionic/osmotic stress may cause an influx of 
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calcium through “stretch-activated” Ca2+ channels Cch1 and Mid1.  The increased 
cytosolic Ca2+ may activate a calcium sensitive pathway to attempt to recover the cell 
from death after significant loss of K+ and ATP at the membrane as well as activate 
intracellular Ca2+/ATPases in order to moderate Ca2+ concentraton(61).  These knockouts 
included ppz1Δ (14.00 ± 3.06%, p < 0.0445), vnx1Δ (23.00 ± 5.57%, p < 0.0539), vcx1Δ 
(108.70 ± 8.19%, p < 0.0056) and pmc1Δ (78.50 ± 2.74%, p < 0.0001) (Figure 6).   
 Pmc1 is a high affinity, vacuolar Ca2+/ATPase that reduces the level of cytosolic 
Ca2+ through vacuolar sequestration.  Its expression is induced by the transcription factor 
Crz1 and calcineurin, a protein phosphatase that regulates intracellular calcium 
concentration.  Calcineurin phosphorylates and inhibits Cch1 and Mid1 directly, in 
addition to activating Pmc1 and inactivating Vcx1.  Vcx1 is a low-affinity vacuolar 
Ca2+/H+ exchanger and is the main restoration pathway for restoring intracellular Ca2+ 
levels post ionic stress induced Ca2+ burst.  In other words, the re-establishment of 
homeostatic levels of Ca2+ after hypertonic shock requires Vcx1p and to a lesser extent 
Pmc1p.  Interestingly the Vcx1 and Pmc1 mutants demonstrated the highest resistance to 
histatin 5 out of all the secondary ion-channels suggesting that calcineurin may play an 
integral role in mitigating the stress induced osmotic shift due to histatin 5.  
 
 
 
 
 
 33 
 
 
 
 
 
 
 
 
 
 
 
Figure 6:  Normalized percent growth of S. cerevisiae ion channel and regulator gene knockouts 
at LD50 of histatin 5. 
 
 Wild type gene Pma2 encodes a cell surface H+/ATPase.  Brp1 is a dubious ORF that is 
upstream to the Pma1 cassette.  Sky1 encodes a serine/threonine protein kinase involved 
in mRNA transport as well as the regulation of Ptk2 and Trk1 gene products.  Trk1 is a 
high affinity K+ transporter at the cell surface.  Pmp1 encodes the regulatory subunit of 
the Pma1 H+/ATPase.  Ppz1 encodes a serine/threonine protein phosphatase involved in 
K+ regulation. Vnx1 encodes a Ca2+/H+ antiporter located at the surface of the 
endoplasmic reticulum. Vcx1 encodes a low affinity vacuolar Ca2+/H+ antiporter involved 
in Ca2+ sequestration at high cytosolic concentrations.  Pmc1 is a high affinity vacuolar 
Ca2+/ATPase that is also involved in cytosolic Ca2+ homeostasis and is regulated by the 
phosphatase calcineurin.  Δ signifies a haploid knockout.  p < 0.05 (*), p < 0.005 (**), p 
< 0.001 (***). 
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IV.c. Genes associated with ionic/osmotic stress response 
 Trk1, under high NaCl stress, is also regulated by the calcium-dependent protein 
phosphatase calcineurin as stated by Forment, Viladevall and Mendoza, possibly due to 
the increase in cytosolic Ca2+ in response to Na+ influx(59),(62),(63).  The calcineurin 
phosphatase (PP2B-type) is active in its full trimeric form(64).  The calcineurin 
holoenzyme is a heterodimer made up of the catalytic subunit (calcineurin A; Cmp2 or 
Cna1) as well as the regulatory subunit (calcineurin B; Cnb1).  Calcineurin B has the 
ability to bind to four Ca2+ molecules and upon doing so will bind and activate 
calcineurin A.  The calcineurin A-B complex can also bind Ca2+/calmodulin complexes 
forming the fully active trimeric form of the enzyme.  Calcineurin is required for yeast to 
survive cation stress as mentioned previously(65).  Calcineurin is of great interest because 
of its ability to be inhibited by the well-known immunosuppressants cyclosporine A and 
FK506(66). 
 Due to the high resistance of the S. cerevisiae sky1Δ mutant to histatin-mediated 
cell death, as well as Sky1 protein interactions with Ptk2 and Trk1 as well as their role in 
Ca2+ influx post deregulation, several calcineurin family member mutants were tested in 
our assay.  Calcineurin regulatory subunit B gene knockout (cnb1Δ) demonstrated 
moderate resistance to histatin 5 treatment with 41.33 ± 2.60% cell growth above the 
control at LD50 (p < 0.0039).  The catalytic subunit A gene knockout (cna1Δ) 
demonstrated significant resistance to histatin 5-induced killing with 68.82 ± 4.03% cell 
growth (p < 0.0001), however, the Cna1 homologue cmp2Δ demonstrated poor resistance 
over control cultures (14.83  ± 2.29%, p < 0.0013), suggesting the primary mode of 
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osmotic stress recovery via calcium regulation may be through the Cmp2 isotype of 
calcineurin in S. cerevisiae.  
 The competitive regulator of catalytic calcineurin A that can either increase or 
decrease enzymatic activity (rcn1Δ mutant) also demonstrated moderate resistance as 
compared to the control (43.67 ± 6.96%, p < 0.0245).  Finally, an upstream regulator of 
calcium ion homeostasis, the zinc-finger transcription factor Crz1, which regulates 
transcription of Pmc1, Pmr1, Pmr2a and Fks2 by binding to the calcineurin-dependent 
response element, was also tested.  The crz1Δ mutant demonstrated significant resistance 
to histatin 5 with 64.75 ± 3.95% growth over the control (p < 0.0005).   
 Two other calcineurin-associated genes were later tested (Frt1 and Gcn2).  Frt1’s 
gene product is also known as Protein Hph1 for high pH protein 1.  It is functionally 
related to Tcp1 protein and is a calcineurin-dependent protein required for growth under 
high NaCl concentrations, very alkaline pH, as well as cell wall stress.  Gcn2 is an 
unrelated serine/threonine kinase that phosphorylates the alpha subunit of eIF-2, 
transcriptionally linking it to regulation of the aforementioned Cmp2 gene product.  
Interestingly, Frt1 and Gcn2 mutants demonstrated high recovery/growth in histatin 5 as 
compared to the control (70.00 ± 2.89%, p < and 76.33 ± 0.33%, p < respectively) 
(Figure 7). 
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Figure 7:  Normalized percent growth of S. cerevisiae osmotic/ionic stress response gene 
knockouts at LD50 of histatin 5. 
 
 Wild type gene Ste11 encodes a MAP kinase kinase kinase involved in regulating 
osmotic stress through multiple pathways.  Pbs2 encodes a Map kinase activated by Ste11 
that subsequently phosphorylates and activates the Hog1 kinase, activating the cascade 
encoded by the Hog1 gene.  The cascade regulates osmotic/ionic stress as well as 
oxidative stress and heavy metal stress through the ultimate production of glycerol.  
Cmp2 gene encodes an isotype of the catalytic subunit of the calcineurin protein 
phosphatase.  Cna1 encodes the other isotype of the catalytic subunit of calcineurin.  
Cnb1 gene product is the regulatory subunit of the calcineurin enzyme.  Rcn1 gene 
encodes a regulatory protein that can either activate or deactivate calcineurin.  Crz1 gene 
encodes the transcription factor that determines the mRNA production of Cmp2 and other 
calcineurin associated products.  Frt1 gene encodes a caclineurin-dependent protein 
required for cellular growth in high NaCl conditions.  Gcn2 gene encodes a 
serine/threonine kinase that phosphorylates calcineurin-regulated proteins such as eIF2.  
Δ signifies a haploid knockout.  p < 0.05 (*), p < 0.005 (**), p < 0.001 (***). 
 
 Calcineurin is inhibited by the immunosuppressive drugs cyclosporin A (CsA) 
and tacrolimus (FK506)(65),(67).  Both CsA and FK506 bind to cell membrane associated 
immunophilins, specifically, CsA binds to cyclophilin A and FK506 binds to the FK506 
binding proteins Fkbp12, Fpr1, Fpr2 and Fpr3, which through target of rapamycin 1 
(Tor1), deactivates the protein phosphatase calcineurin(66).  Fpr1, Fpr2 and Fpr3 
knockouts were tested and demonstrated significant resistance to histatin 5 mediated cell 
death (fpr1Δ: 28.67 ± 1.45, p < 0.0026; fpr2Δ: 86.50 ± 1.00, p < 0.0001; fpr3: 80.33 ± 
6.67, p < 0.0068) (Figure 8).  These data additionally support the importance of 
calcineurin in mitigating histatin 5-induced osmotic stress.  A full knockout of binding 
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proteins necessary for inhibition of calcineurin allow for a fully unregulated protein 
phosphatase to bind to and regulate Ca2+ intracellularly in response to hyperosmolarity as 
well as regulate the cell surface transporters Trk1 and Mid1. 
 
 
 
 
 
 
 
 
 
 
Figure 8:  Normalized percent growth of S. cerevisiae FK506 binding protein gene knockouts at 
LD50 of histatin 5. 
 
 Wild type genes Fpr3, Fpr2 and Fpr1 encode FK506 binding proteins that when bound to 
FK506 inactivate the protein phosphatase calcineurin. Δ signifies a haploid knockout.  p 
< 0.05 (*), p < 0.005 (**), p < 0.001 (***). 
 
 While the calcineurin pathway may be the key regulator of calcium homeostasis 
in response to ionic stress, ultimately it is encompassed by and linked to the larger 
mitogen-activated protein kinase (MAPK) pathways, one of which is Hog1.  The high-
osmolarity glycerol (Hog1) pathway is a major player in the adaptation to osmotic, 
oxidative and heavy metal stresses through its downstream production of the 
osmoprotectant glycerol(68),(69).  If histatin 5 induces rapid loss of cytosolic fluid through 
the efflux of several ions and ATP, then it can be assumed that in order to survive such a 
stress, cells would activate a MAPK pathway.  Indeed Vylkova and colleagues have 
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demonstrated that Hog1 is preferentially phosphorylated in C. albicans upon histatin 5 
induced stress and that mutants lacking the kinase demonstrated hypersensitivity to 
histatin 5(44).  Pbs2, an upstream kinase in the pathway, activates Hog1 kinase through 
sequential phosphorylation.  Both knockouts pbs2Δ and hog1Δ were tested in our assay 
and demonstrated 5.33 ± 0.33% and 5.33 ± 0.71% growth respectively (p < 0.0001, p < 
0.0007). 
 Ste11p is the S. cerevisiae homologue of the mammalian MEKK1, a mitogen-
activated protein kinase kinase kinase (MAPKKK) that regulates mating, invasive growth 
and osmotic stress MAPK cascades(70).  Within the osmotic stress cascade is the 
aforementioned Hog1 kinase regulated by Pbs2, which is initially phosphorylated by 
Ste11p.  Ste11p then is the initiating step in the activation of the Hog1 cascade in 
response to ionic/osmotic stress.  Interestingly, the previously mentioned spermidine 
permease Ptk2 and Cmk2, a redundant calmodulin dependent kinase regulated by the 
transcription factor Crz1p, are also direct substrates of Ste11p.  As such, Ste11 is an 
integral kinase in linking multiple pathways including calcineurin, Hog1 and membrane-
associated channels in response to cellular stress.  The Ste11 knockout (ste11Δ) did in 
fact demonstrate no resistance to histatin 5 induced cell death (8.50 ± 0.56%, p < 0.0001) 
(Figure 7). 
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IV.c. Genes associated with the regulation of reactive oxygen species 
 Our data up until this point suggested that histatin 5 may act primarily through the 
proposed mechanism by Edgerton and colleagues through altering ion homeostasis in the 
cell leading to ATP efflux, osmotic shift and eventually non-cytolytic cell death.  
Deregulation of conductance via histatin 5 could be achieved through the disruption of 
multiple voltage-gated membrane channels as well as their regulators such as the 
calcineurin-calmodulin complex under stress conditions.  However, after completing a 
protein database search, additional genes of interest were discovered and tested, with 
significant results suggesting the possibility of reactive oxygen species formation as not a 
separate theory but continuous with the ion imbalance hypothesis, with both pathways 
attributing to non-cytolytic cell death via histatin 5.  These genes included Tom71, 
Tim21, Sod2, Gpx2, Hyr1, Yap1, Ctt1, Tsa2, and Ure2 (Figure 9). 
 In order to produce free radical species, which lead to oxidative damage, histatin 
5 must travel to and enter the mitochondria and inhibit respiration along the electron 
transport chain.  A means of transport, we believe, is the Ssa1 Hsp70 chaperone which 
has already been implemented as a binding receptor for histatin 5 at the cell 
surface(38),(39).  Ssa1 has been shown to associate with emerging translated mRNAs 
directed for the mitochondria as well as bind to Tom70 to facilitate the transport of the 
unfolded protein through the outer mitochondrial membrane, into the inner mitochondrial 
membrane and mitochondrial matrix(71).   Usually mitochondrial matrix preproteins 
contain N-terminal targeting sequences forming amphiphatic helices.  While it has 
previously been described that histatin 5 most likely is not amphiphathic in nature, it has 
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been shown to bind to Ssa1 and may contain a mimic targeting sequence allowing for its 
entrance into yeast mitochondria.   
 Mitochondrial directed preproteins shuttle into the mitochondria through the 
translocase of the outer membrane (TOM) family and translocase of the inner membrane 
(TIM) family proteins along with modulator proteins and linkers (presquence translocase-
associated motor complex: PAM and J-proteins). The TOM complex has two surface 
receptors Tom20 and Tom70 on the mitochondrial membrane(72).  Tom20 recognizes the 
N-terminal target sequences of the preproteins and Tom70 binds to internal targeting 
sequences along the protein as well as recruits the secondary scaffold proteins (PAM) 
involved in the motor complex, when in association with Hsp70.  Tom70 interacts with 
Hsp70 via a peptide-binding groove in its N-terminus specific for the C-terminal EEVD 
motif within Hsp70/Hsp90 proteins(73),(74).  Tom70 then passes along the protein in a 
threading fashion to Tim23, which in turn is driven by the electrical potential across the 
inner membrane.  The final reassociation with the PAM complex allows for the unfolding 
of the polypeptide chain and its ultimate transport into the matrix where mitochondrial 
processing peptidase (MPP) will proteolytically remove the targeting sequence on the 
nascent peptide and refold the protein(75). 
 In our assay, we tested Tom71, a 639 amino acid homologue of Tom70 with > 
50% sequence identity.  The knockout tom71Δ demonstrated 54.67 ± 3.94% growth over 
control (p < 0.0001).  A translocase of the inner membrane Tim 21 mutant tim21Δ was 
also tested and again demonstrated significant growth over the control (65.80 ± 6.29%, p 
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< 0.0005) suggesting that indeed histatin 5 may enter into the mitochondria through TOM 
and TIM via its association with the Ssa1 Hsp70 chaperone. 
 Histatin 5 upon entering the mitochondria is proposed to cause disruption at 
complex I of the respiratory chain ultimately producing the superoxide anion radical 
(O2−) which can damage cellular DNA, proteins, and lipids(45),(48),(76).  Under homeostatic 
aerobic respiration, enzymes called superoxide dismutases disproportionate the 
superoxide radical to produce molecular oxygen (O2) and hydrogen peroxide (H2O2).  
The H2O2 formed also is harmful to the cell and as such it is decomposed to O2 and H2O 
by catalases or reduced to H2O by peroxidases which are commonly named by their 
reducing factor(77).  
 Unfortunately, no viable respiratory chain knockouts were available to test in our 
assay in order to elucidate the generation of reactive oxygen species.  However, the 
aforementioned proteins upregulated in the presence of peroxides such as superoxide 
dismutase, catalyzing agent (catalase T) and reducing agents (glutathione 
peroxidase/thioredoxin peroxidase) mutants were tested to verify possible death via 
histatin 5 induced ROS generation.  These genes and associated gene products included 
Sod2, Gpx2, Hyr1, Yap1, Tsa2, Ctt1 and Mca1. 
 Superoxide dismutase 2 (Sod2) is a mitochondrial enzyme that through the use of 
a manganese cofactor catalyzes the disproportionation of O2− in turn producing O2 and 
H2O2 and minimizing oxidative stress(78).  Other than glutathione peroxidase and 
thioredoxin peroxidase, Sod2 is the main enzyme necessary for regulating free radical 
production and protection from their subsequent ROS damage in the mitochondria.  A 
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Sod2 mutant (sod2Δ) was tested with the anticipation that cells would respond poorly to 
histatin 5 treatment due to the decrease in enzymatic recovery against harmful ROS.  
Indeed, sod2Δ cells demonstrated only 4.63 ± 0.80% growth over control (p < 0.0007). 
 Gpx2 is a member of one of three glutathione peroxidases found in S. cerevisiae. 
Like Gpx1, Gpx2 functions to reduce H2O2 into H2O via glutathione and thioredoxin 
reducing agents, while Gpx3 also known as Hyr1 acts within a transduction pathway to 
activate the basic leucine zipper transcription factor Yap1, a regulator of the adaptive 
response to oxidative stress(77),(79),(80).  Gpx2 is distributed both in the cytoplasm and 
mitochondria of the respiring cell, unlike Sod2, which is restricted to the mitochondria.  
In our assay we tested the Gpx2 peroxidase, the Gpx3 (Hyr1) peroxidase and the Yap1 
transcription factor mutants. The gpx2Δ and hyr1Δ mutants provided poor resistance to 
histatin 5 upon knockout (4.83 ± 0.98%, p < 0.044; 3.50 ± 0.56% p < 0.0016).  The 
yap1Δ mutant provided moderate resistance (21.17 ± 1.52%, p < 0.0001).   
 Cytosolic catalase T ctt1Δ as well as stress inducible cytosolic thioredoxin 
peroxidase tsa2Δ mutants were also tested and demonstrated 2.50 ± 0.56% and 3.83 ± 
0.65% growth over control respectively (p < 0.0067, p < 0.002).   These data suggest that 
free radical scavengers in S. cerevisiae are necessary to mediate cell recovery from 
histatin 5 mediated cell death, possibly due to their role in the protection against 
generated reactive oxygen species. 
 Ure2 plays a central role in nitrogen catabolite repression by acting as a 
transcriptional regulator, inhibiting Gln3 transcription for glutamine metabolism(81).  
Ure2 also interestingly has glutathione peroxidase activity and can mutate to acquire 
 43 
glutathione-S-transferase (GST) activity(82).  Due to the glutathione-like activity of Ure2 
it could be hypothesized that if histatin 5 travels to the mitochondria to inhibit respiratory 
complex I, producing the highly reactive CoQ semiquinone radical (CoQ.-), or produces 
reactive oxygen species through another mechanism, an upregulation of scavengers such 
as glutathione peroxidase and GST would be necessary to recover the cell from induced 
cell death.  Ure2 would then arguably be upregulated to serve as an additional scavenger 
along with glutathione peroxidase, thioredoxin peroxidase and catalase.  However, there 
are some faults with this theory that suggests otherwise.  While it is true that ure2Δ 
mutants are hypersensitive to cadmium, nickel ions and hydrogen peroxide(82), it has been 
shown in our assay that a full ure2Δ knockout protects S. cerevisiae from histatin 5 
induced degradation as demonstrated by 97.83 ± 0.91% growth when compared to 
control cultures (p < 0.0001) (Figure 9).   
 With these data, and continuous with the hypothesis of free radical production by 
histatin 5, Ure2’s main function cannot be of scavenger basis.  Rodriguez and colleagues 
have in a recent publication described Ure2 and its potential role with salt tolerance via 
Ca+ homeostasis and calcineurin activation in the yeast Hansenula polymorpha(83).  In 
their report they state that a ure2Δ strain demonstrates increased tolerance to Na+ and Li+ 
due to the extrusion of Na+ from the cell through expression of the ATPase gene Ena1.  
They also state that through the use of the calcineurin inhibitor FK506 they observed 
increased sensitivity in ure2Δ mutants even in the absence of Na+ and Li+ suggesting that 
Ure2 in its native state has a positive effect on calcineurin activation.  When deleted, an 
upregulation of Pmr1 via Gat2 is hypothesized to occur, which ultimately leads to a 
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decrease in Ca2+ entry into the cell and a reduced cytosolic Ca2+ store, paralleling the 
endogenous effects of calcineurin during salt stress(83).   
 In addition, it has been proposed that Ure2 through its C-terminal domain 
interacts with the molecular chaperone Ssa1p in a 1:1 complex, which may affect Ssa1 
binding to histatin 5 at the cell surface or within the cytosol, and may explain the high 
resistance to histatin treatment upon knockout(84).  Ure2 then does not play a significant 
role as a scavenger in S. cerevisiae during histatin 5 induced cell death, but rather plays 
an adaptive role in modulating histatin 5 binding to the Hsp70 family member Ssa1.  
Ure2 may provide the intriguing link between the osmotic stress pathway and oxidative 
stress pathway in histatin 5 induced cell death. 
 
 
 
 
 
 
 
 
Figure 9:  Normalized percent growth of S. cerevisiae reactive oxygen species regulating gene 
knockouts at LD50 of histatin 5. 
 
 Wild type genes Tom71 and Tim21 encode proteins in the TOM and TIM complexes 
respectively.  Sod2 gene encodes a superoxide dismutase.  Gpx2 and Hyr1 genes encode 
glutathione peroxidases.  Yap1 encodes a protein involved in the regulation of 
peroxidases.  Ctt1 gene encodes a catalase.  Tsa2 gene encodes a thioredoxin peroxidase.  
Ure2 encodes a transcriptional regulator involved in oxidative stress and ionic stress.  Δ 
signifies a haploid knockout.  p < 0.05 (*), p < 0.005 (**), p < 0.001 (***). 
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IV.d. Genes involved in cell wall integrity  
 Several genes involved in cell wall structure and integrity were tested in order to 
reaffirm that histatin 5 operates through a different mechanism than the common azole, 
amphotericin, and echinocandin classes of drugs.  These genes included Exg1, Chs3, 
Van1, Erg4 and Azr1.  Exg1 is the major exo-1,3-beta-glucanase of the cell wall involved 
in beta-glucan assembly, specifically through the addition of  sugar residues onto surface 
proteins and starches(85).  Chs3 gene encodes chitin synthase III, which catalyzes the 
transfer of N-acetylglucosamine to chitin.  Chitin synthase III is a necessary enzyme 
required for the synthesis of the majority of cell wall chitin(86).  Van1 is the first 
component of mannan synthesis, i.e. mannose polymerization(87).  Erg4 gene encodes a 
24-carbon sterol reductase that catalyzes the last step in ergosterol biosynthesis; 
ergosterol being the major fluidic component through which azole and polyene drugs 
operate(88).  Finally, Azr1 encodes the plasma membrane transporter of the major 
facilitator superfamily, which is the main mechanism of adaptive resistance to 
ketoconazole and fluconazole(89).  All these genes upon knockout still provide viable 
yeast culture in vitro.  The knockouts in our assay all demonstrated moderate to poor 
resistance to histatin 5 treatment, suggesting that histatin does not need an intact cell wall 
to operate unlike the common treatments for oral candidiasis.  exg1Δ: 10.67 ± 0.67%, p < 
0.0039; chs3Δ: 39.00 ± 2.89%, p < 0.0054; van1Δ: 13.33 ± 1.45%, p < 0.0117; erg4Δ: 
18.33 ± 1.45%, p < 0.0062; azr1Δ: 12.33 ± 1.20%, p < 0.0094 (Figure 10). 
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Figure 10:  Normalized percent growth of S. cerevisiae cell wall integrity gene knockouts at 
LD50 of histatin 5. 
 
 Wild type gene Exg1 encodes an exo-1,3-beta-glucanase involved in glycosylation at the 
cell wall.  Chs3 gene encodes a chitin synthase III which produces the majority of the cell 
wall chitin.  Van1 gene encodes a component involved in mannose polymerization.  Erg4 
gene encodes a sterol reductase involved in the final step of ergosterol biosynthesis at the 
cell wall.  The Azr1 gene encodes a plasma membrane transporter within the major 
facilitator superfamily that is overexpressed in response to antifungal drugs such as 
ketoconazole and fluconazole.  Δ signifies a haploid knockout.  p < 0.05 (*), p < 0.005 
(**), p < 0.001 (***). 
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V.  DISCUSSION 
 
  Oral candidiasis is an increasing health concern among elderly and 
immunocompromised patients such as those suffering from AIDS.  While treatment is 
readily available, the common pharmaceuticals are becoming exponentially ineffective 
due to the rapid development of resistant yeast strains and biofilms.  With the major 
mechanism of candidacidal activity of approved therapies involving the disruption of 
structural proteins or sterols at the cell wall, it is pertinent to uncover biologics operating 
through different stress induced pathways.  For many years, histatin 5, a cationic peptide 
endogenously produced in the oral cavity has been of great interest due to its potent 
antifungal properties.  However, while the use of the peptide as a potential therapy has 
evolved, its mechanistic of action still remains unclear.  In order to elucidate the 
molecular pathways involved in histatin-mediated death, a haploid gene knockout library 
of S. cerevisiae was analyzed in vitro.  Many genes were tested and categorized based on 
relative resistance to histatin 5 upon knockout.  The proposed mechanism of histatin 5 
induced cell death in S. cerevisiae is as follows. 
 Histatin 5 initially binds to the Hsp70 co-chaperone Ssa1 at the cellular surface.  
Ssa1 does not internalize with bound histatin 5 but rather transfers the peptide to a non-
specific spermidine/polyamine transporter such as Ptk2 or Dur3.  Upon the transfer and 
internalization of histatin 5, the activated Ptk2 transporter in turn activates the P-type 
surface H+/ATPase Pma1.  H+ and other ions are rapidly pumped from the cytosol to the 
extracellular space, which shunts the cell into osmolar imbalance in turn activating the K+ 
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transporters Trk1 and Tok1.  The deregulation of these surface voltage-gated ion 
channels creates a hypertonic shock to the cell where efflux of ATP and other ions occurs 
along with loss of water.   
 “Stretch-activated” Ca2+ channels such as Cch1 or Mid1 are activated during 
membrane depolarization and participate in increasing cytosolic Ca2+ levels.  The high-
levels of calcium ultimately activate the osmotic stress response pathway, specifically at 
the level of the protein phosphatase calcineurin, which attempts to recover the cell from 
stress by shutting down the surface K+ transporter Trk1 and the “stretch-activated” Ca2+ 
channels, as well as activating vacuolar Ca2+/ATPase Pmc1 to sequester the increased 
cytosolic calcium.  Encompassing and regulating calcineurin is the MAP kinase cascade 
activated by Ste11 MAP kinase kinase kinase as well as downstream kinases Pbs2 and 
Hog1.  The osmotic stress kinase cascade, along with calcineurin, attempt to return the 
cell to ionic homeostasis.  The high osmolarity glycerol kinase Hog1 also plays an 
important role in responding to oxidative and heavy metal stress(44),(68),(70).   
 The initial hyperosmolar sensitivity and potential deregulation does not by itself 
lead to cell death.  Rather, in addition, internalized histatin 5 binds to cytosolic Ssa1 
Hsp70, which transports the peptide to the surface of the mitochondria and through the 
TOM/TIM complex allows for its internalization.  Histatin 5 may then disrupt the 
electron transport chain at respiratory complex I and/or III and aid in the production of 
reactive oxygen species, which ultimately damage DNA, proteins and lipids leading to 
cell death (Figure 11). 
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 In summary, histatin 5, through its initial disruption of surface ion channels such 
as Trk1 and Pma1, sends cells into osmolar shock, which may link to and aid in the 
production of reactive oxygen species(90).  Histatin 5 itself may also internalize into the 
mitochondria and disrupt the electron transport chain in the actively respiring yeast, again 
producing ROS.  Unfortunately, histatin 5 interacts with the mitochondria in a currently 
unresolved fashion.  Limited access to viable mutants did not clarify the specific factors 
necessary in ROS production.  However, viable peroxidase, dismutase and catalase 
knockouts demonstrated lack of resistance to histatin 5 and possible slight 
hypersensitivity, suggesting the production of free radicals and reactive oxygen species in 
cells treated with histatin 5.  As such, the opposing theories of action of histatin 5 leading 
to osmotic stress and oxidative stress may in fact work in tandem rather than in 
opposition.  Additional research is required to fully uncover the mechanism of histatin 5 
induced cell death in Saccharomyces cerevisiae. 
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Figure 11:  The proposed mechanism of histatin 5 induced cell death in S. cerevisiae as depicted 
in cartoon form. 
 
 Histatin 5 binds to the heat shock protein Ssa1 at the cell surface, which then transports 
histatin 5 to a polyamine transporter such as Ptk2 or Dur3 (1).  Histatin 5 travels through 
the transporter along with spermidine and other polyamines.  The phosphorylated Ptk2 
permease further activates the P-cation-type pump Pma1 at the cell surface (2).  Pma1, 
through active transport, generates an osmotic gradient within the cell via the movement 
of H+ and other ions from intracellular to extracellular.  The initial hyperosmolar 
sensitivity activates the Trk1 and Tok1 K+ transport systems, which ultimately lead to 
membrane depolarization and ATP efflux, along with a total decrease in cytosolic volume 
(3).  This osmotic/ionic stress turns on “stretch-activated” Ca2+ channels Mid 1 and Cch1 
(4).  A spike in cytosolic Ca2+ is noticed and responded to by the protein phosphatase 
calcineurin, which inhibits Mid1 and Cch1 as well as Trk1 (5).  In addition, the Ste11 
Map kinase kinase kinase activates a Map cascade which ultimately upregulates 
calcineurin production as well as glycerol production through the Hog1 kinase 
intermediate (6).  Ste11 also inhibits Pma1 directly. 
 
 In addition to altering ion movement at the cell surface, internalized histatin 5 binds to 
cytosolic Ssa1 protein, which shuttles the peptide to the membrane of the mitochondria 
(A).  At the mitochondrial membrane, Ssa1 binds to Tom71 and transfers histatin 5 to the 
TOM complex which through TIM proteins and PAM and J-proteins, shuttles histatin 5 
into the matrix of the mitochondria (B).  Within the mitochondria, histatin 5 interferes 
with respiratory complexes I/III, which in turn produces highly reactive free radicals and 
reactive oxygen species (C).  These species kill the cell through damage to DNA, lipids 
and proteins. 
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APPENDIX 
Systemic Name 
(Standard Name) 
Associated Protein’s 
Biological Function 
Cellular Localization Relative Percent 
Growth in histatin 5 
YJL129C 
(Trk1) 
Main potassium channel 
involved in regulation of 
membrane potential 
Plasma membrane 129.70 ± 6.77 
YDL128W 
(Vcx1) 
Low-affinity vacuolar 
Ca2+/H+ antiporter 
Cytosol, vacuolar 
membranes 
108.70 ± 8.19 
YHL016C 
(Dur3) 
Transporter of urea and 
polyamines 
Plasma membrane 100.70 ± 2.33 
YBR132C 
(Agp2) 
High-affinity polyamine 
permease 
Plasma, vacuolar and 
endoplasmic reticulum 
membranes 
100.00 ± 1.53 
YJR059W 
(Ptk2) 
Putative serine/threonine 
protein kinase involved 
in ion transport and 
spermine/polyamine 
uptake 
Plasma membrane, 
cytoplasm, nucleus 
93.83 ± 1.53 
YNL229C 
(Ure2) 
Nitrogen catabolite 
repression 
transcriptional regulator 
with glutathione activity 
Cytosol 97.83 ± 0.91 
YMR216C 
(Sky1) 
Serine/threonine protein 
kinase involved in 
regulation proteins 
involved in mRNA 
metabolism and cation 
homeostasis 
Cytosol 95.67 ± 2.33 
YGL007W 
(Brp1) 
Dubious ORF located 
upstream to Pma1 
Unknown 94.67 ± 0.88 
YKR039W 
(Gap1) 
General amino acid 
permease 
Plasma membrane, ER, 
golgi, endosome, 
vacuolar lumen, 
multivesicular body 
91.00 ± 6.35 
YPL274W 
(Sam3) 
High-affinity S-
adenosylmethionine 
permease 
Plasma membrane 86.67 ± 0.88 
YDR519W 
(Fpr2) 
Membrane-bound 
peptidyl-prolyl cis-trans 
isomerase that binds to 
FK506 and rapamycin 
Endoplasmic reticulum 
membrane, cytosol, 
nucleus 
86.50 ± 1.00 
YNL135C 
(Fpr1) 
Peptidyl-prolyl cis-trans 
isomerase that binds to 
FK506 and rapamycin 
Cytosol, mitochondria, 
nucleus 
80.33 ± 6.67 
YGL006W 
(Pmc1) 
Vacuolar Ca2+/ATPase 
involved in depleting the 
cytosol of Ca2+ ions 
Vacuolar membrane 78.50 ± 2.74 
YDR283C 
(Gcn2) 
Protein kinase that 
phosphorylates 
translation initiation 
factor eIF2 
Cytosolic ribosome 76.33 ± 0.33 
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YOR324C 
(Frt1) 
Substrate of phosphatase 
calcineurin 
Endoplasmic reticulum 70.00 ± 2.89 
YBR069C 
(Tat1) 
Amino acid transporter 
for valine, leucine, 
isoleucine and tyrosine 
Plasma membrane 69.50 ± 10.97 
 YPL036W 
(Pma2) 
Plasma membrane 
H+/ATPase involved in 
the regulation of 
membrane potential and 
cytosolic pH 
Plasma membrane, 
mitochondria 
69.33 ± 4.91 
YLR433C 
(Cna1) 
The catalytic subunit of 
calcineurin involved in 
Ca2+ ion homeostasis 
Cytoplasm 68.82 ± 4.03 
YGR033C 
(Tim21) 
Subunit of the 
translocase of the inner 
membrane (TIM23 
complex) 
Mitochondrial 
membrane (inner) 
65.80 ± 6.29 
YNL027W 
(Crz1) 
Transcription factor that 
activates the 
transcription of stress 
response genes such as 
calcineurin 
Cytoplasm, nucleus 64.75 ± 3.95 
YCR024C-A 
(Pmp1) 
Regulatory subunit for 
the H+/ATPase Pma1p 
Plasma membrane 63.50 ± 3.50 
YOR273C 
(Tpo4) 
Polyamine transporter of 
the major facilitator 
superfamily 
Plasma membrane, 
vacuolar membrane 
62.00 ± 5.57 
YAL005C 
(Ssa1) 
ATPase involved in 
protein folding and 
NLS-directed nuclear 
transport, member of the 
Hsp70 family 
Cell wall, plasma 
membrane, vacuolar 
membrane, cytoplasm, 
polysome, mitochondria, 
nucleus 
55.67 ± 4.10 
YHR117W 
(Tom71) 
Mitochondrial outer 
membrane component 
of the translocase of the 
outer membrane (TOM 
complex) 
Mitochondrial 
membrane (outer) 
54.67 ± 3.94 
YKL159C 
(Rcn1) 
Protein involved in 
calcineurin regulation 
during calcium signaling 
Cytoplasm 43.67 ± 6.96 
YKL190W 
(Cnb1) 
The regulatory subunit 
of calcineurin a 
Cytoplasm  41.33 ± 2.60 
YBR023C 
(Chs3) 
Chitin synthase III, 
catalyzes the transfer of 
N-acetylglucosamine to 
chitin on the cell wall 
Cell wall, cytoplasm 39.00 ± 2.89 
YML074C 
(Fpr3) 
Nucleolar peptidyl-
prolyl cis-trans 
isomerase FK506 
binding protein 
Nucleolus 28.67 ± 1.45 
YNL321W 
(Vnx1) 
Ca2+/H+ antiporter 
located at the ER 
Endoplasmic reticulum, 
vacuole membrane 
23.00 ± 5.57 
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YML007W 
(Yap1) 
Transcription factor 
required for oxidative 
stress tolerance, 
activated by H2O2  
Cytoplasm, 
nucleus 
21.17 ± 1.52 
YGL012W 
(Erg4) 
Sterol reductase, 
catalyzes the first step in 
ergosterol biosynthesis 
Endoplasmic reticulum, 
plasma membrane 
18.33 ± 1.45 
YML057W 
(Cmp2) 
An isoform of the 
catalytic subunit 
calcineurin A 
Cytoplasm 14.83 ± 2.29 
YML016C 
(Ppz1) 
Serine/threonine protein 
phosphatase Z involved 
in the regulation of K+ 
transport 
Plasma membrane, 
cytoplasm, nucleus 
14.00 ± 3.06 
YML115C 
(Van1) 
Component of mannan 
polymerase I, catalyzes 
first steps of mannan 
synthesis 
Endoplasmic reticulum 13.33 ± 1.45 
YGR224W 
(Azr1) 
Plasma membrane 
transporter of the major 
facilitator superfamily, 
involved in resistance to 
azole drugs 
Plasma membrane 12.33 ± 1.20 
YLR300W 
(Exg1) 
Major exo-1,3-beta-
glucanase of the cell 
wall, involved in beta-
glucan assembly 
Cell wall 10.67 ± 0.67 
YLR362W 
(Ste11) 
Signal transducing MEK 
kinase involved in a 
variety of pathways 
including pheromone 
response and oxidative 
stress via Hog1 kinase 
Cytoplasm 8.50 ± 0.56 
YJL128C 
(Pbs2) 
Map kinase kinase of 
the HOG signaling 
pathway involved in 
sever osmotic stress and 
oxidative stress 
Cytoplasm 5.33 ± 0.33 
YLR113W 
(Hog1) 
Map kinase involved in 
osmoregulation through 
the production of 
glycerol 
Cytoplasm, 
nucleus 
5.33 ± 0.71 
YBR244W 
(Gpx2) 
Glutathione peroxidase, 
protects cells from 
phospholipid 
hydroperoxides during 
oxidative stress 
Cytoplasm, 
nucleus 
4.83 ± 0.98 
YHR008C 
(Sod2) 
Mitochondrial 
manganese superoxide 
dismutase, protects cell 
against oxygen toxicity 
Mitochondria 4.63 ± 0.80 
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YDR453C 
(Tsa2) 
 
Stress-inducible 
thioredoxin peroxidase, 
increases in response to 
DNA stress 
Cytoplasm 3.83 ± 0.65 
YIR037W 
(Hyr1) 
Thiol peroxidase, 
functions as a 
hydroperoxide receptor 
to sense intracellular 
hydroperoxide levels 
and transduce a redox 
signal to the Yap1p 
transcription factor 
 
Mitochondrial 
membrane space, 
cytoplasm 
3.50 ± 0.56 
YGR088W 
(Ctt1) 
Cytosolic catalase T, 
protects from oxidative 
damage by H2O2 
Cytoplasm 2.50 ± 0.56 
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